Miglinon drops and preparing method thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- FUKANGREN BIO PHARMA
- Publication Date
- 2006-08-16
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
technical field
[0001] The invention relates to a novel pharmaceutical preparation, in particular to mitiglinide dripping pills for treating hepatitis B and a preparation method thereof. Background technique
[0002] Diabetes mellitus (Diabetes mellitus) is a syndrome of glucose, protein and lipid metabolism disorders caused by insulin deficiency or insulin cell metabolism defects. Proper control can lead to chronic complications in tissues and organs such as eyes, kidneys, nerves, blood vessels, and heart, and eventually lead to blindness, lower limb gangrene, uremia, cerebral apoplexy or myocardial infarction, and even life-threatening. Diabetes is a common disease. With the improvement of living standards, the incidence of diabetes is increasing year by year. The prevalence of diabetes in developed countries has reached 5%-10%, and the prevalence in my country has reached 3%.
[0003] Miglinide is the third meglitaide drug after repaglinide and nateglinide, and it is a ...